174 related articles for article (PubMed ID: 12537672)
41. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
[TBL] [Abstract][Full Text] [Related]
42. Radioimmunotherapy with 153Sm-CEA monoclonal antibody in nude mice bearing human colon carcinoma: an experimental study.
Li GP; Zhang H; Zhu CM
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):1-5. PubMed ID: 12527502
[TBL] [Abstract][Full Text] [Related]
43. Adjuvant radioimmunotherapy after radiofrequency ablation of colorectal liver metastases in an experimental model.
de Jong G; Hendriks T; Franssen G; Oyen W; Boerman O; Bleichrodt R
Eur J Surg Oncol; 2011 Mar; 37(3):258-64. PubMed ID: 21208773
[TBL] [Abstract][Full Text] [Related]
44. [186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.
Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E
Nucl Med Biol; 1998 Jan; 25(1):37-45. PubMed ID: 9466360
[TBL] [Abstract][Full Text] [Related]
45. Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice.
Sun LQ; Vogel CA; Mirimanoff RO; Coucke P; Slosman DO; Mach JP; Buchegger F
Cancer Res; 1997 Apr; 57(7):1312-9. PubMed ID: 9102219
[TBL] [Abstract][Full Text] [Related]
46. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.
Pedley RB; Hill SA; Boxer GM; Flynn AA; Boden R; Watson R; Dearling J; Chaplin DJ; Begent RH
Cancer Res; 2001 Jun; 61(12):4716-22. PubMed ID: 11406542
[TBL] [Abstract][Full Text] [Related]
47. Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations.
Chalandon Y; Mach JP; Pèlegrin A; Folli S; Buchegger F
Anticancer Res; 1992; 12(4):1131-9. PubMed ID: 1503403
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases.
de Jong GM; Hendriks T; Eek A; Oyen WJ; Nagtegaal ID; Bleichrodt RP; Boerman OC
Ann Surg; 2011 Feb; 253(2):336-41. PubMed ID: 21217519
[TBL] [Abstract][Full Text] [Related]
49. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
[TBL] [Abstract][Full Text] [Related]
50. Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol.
Visser GW; Gerretsen M; Herscheid JD; Snow GB; van Dongen G
J Nucl Med; 1993 Nov; 34(11):1953-63. PubMed ID: 8229241
[TBL] [Abstract][Full Text] [Related]
51. Treatment with unlabeled mAb BR96 after radioimmunotherapy with 177Lu-DOTA-BR96 in a syngeneic rat colon carcinoma model.
Eriksson SE; Ohlsson T; Nilsson R; Tennvall J
Cancer Biother Radiopharm; 2012 Apr; 27(3):175-82. PubMed ID: 22417248
[TBL] [Abstract][Full Text] [Related]
52. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.
Colnot DR; Quak JJ; Roos JC; van Lingen A; Wilhelm AJ; van Kamp GJ; Huijgens PC; Snow GB; van Dongen GA
J Nucl Med; 2000 Dec; 41(12):1999-2010. PubMed ID: 11138685
[TBL] [Abstract][Full Text] [Related]
53. Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
Ma D; McDevitt MR; Barendswaard E; Lai L; Curcio MJ; Pellegrini V; Brechbiel MW; Scheinberg DA
Leukemia; 2002 Jan; 16(1):60-6. PubMed ID: 11840264
[TBL] [Abstract][Full Text] [Related]
54. A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.
Aarts F; Hendriks T; Boerman OC; Koppe MJ; Oyen WJ; Bleichrodt RP
Ann Surg Oncol; 2007 Nov; 14(11):3274-82. PubMed ID: 17653591
[TBL] [Abstract][Full Text] [Related]
55. 186Rhenium-HNK1 monoclonal antibody targets human small cell lung cancer cells in athymic nude mice: rapid screening model for therapy.
Koros AM; Tobin MJ; Epperly MW; Levine G; McGinley JR
Anticancer Res; 1993; 13(6A):1953-6. PubMed ID: 7507652
[TBL] [Abstract][Full Text] [Related]
56. Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide.
Janssen ML; Pels W; Massuger LF; Oyen WJ; Boonstra H; Corstens FH; Boerman OC
Int J Gynecol Cancer; 2003; 13(5):607-13. PubMed ID: 14675343
[TBL] [Abstract][Full Text] [Related]
57. Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
Koppe MJ; Oyen WJ; Bleichrodt RP; Verhofstad AA; Goldenberg DM; Boerman OC
Cancer Biother Radiopharm; 2006 Oct; 21(5):506-14. PubMed ID: 17105422
[TBL] [Abstract][Full Text] [Related]
58. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice.
Buchegger F; Rojas A; Delaloye AB; Vogel CA; Mirimanoff RO; Coucke P; Sun LQ; Raimondi S; Denekamp J; Pèlgrin A
Cancer Res; 1995 Jan; 55(1):83-9. PubMed ID: 7805046
[TBL] [Abstract][Full Text] [Related]
59. Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.
Kelly MP; Lee FT; Smyth FE; Brechbiel MW; Scott AM
J Nucl Med; 2006 Apr; 47(4):716-25. PubMed ID: 16595507
[TBL] [Abstract][Full Text] [Related]
60. Radioimmunotherapy for liver micrometastases in mice: pharmacokinetics, dose estimation, and long-term effect.
Saga T; Sakahara H; Nakamoto Y; Sato N; Zhao S; Iida Y; Kuroki M; Endo K; Konishi J
Jpn J Cancer Res; 1999 Mar; 90(3):342-8. PubMed ID: 10359050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]